Top

Clinical Rheumatology

Published in:

01-09-2020 | Electrocardiography | Original Article

Evaluation of cardiac autonomic nervous system in patients with ankylosing spondylitis using 12-lead electrocardiography and Holter monitoring

Authors: Mustafa Candemir, Burcu Candemir, Adem Ertürk

Published in: Clinical Rheumatology | Issue 9/2020

Abstract

Objectives

Ankylosing spondylitis (AS) is associated with increased risk of cardiovascular problems, including complications such as conduction defects and arrhythmias, which might lead to increased morbidity and/or mortality. The objective of the present study is to evaluate the electrocardiographic (ECG) parameters, including T-peak to T-end intervals (Tpe), Tpe/corrected QT (QTc) ratio, heart rate variability (HRV), and heart rate turbulence (HRT) in AS patients.

Methods

Seventy-six AS patients and 55 control subjects were included in the study. 12-lead ECG and 24-h Holter monitoring recordings were obtained. Tpe and Tpe/QTc were measured using the 12-lead ECG and HRV and HRT parameters were assessed using 24-h Holter ECG recordings. Subjects were assigned into three groups based on their HRT parameters (Tonset (TO) and Tslope (TS)) (HRT-0, normal TO or TS; HRT-1, abnormal TO or TS; HRT-2, abnormal TO and TS).

Results

Tpe was prolonged and Tpe/QTc ratio was higher in AS patients (p < 0.001 for both). Moreover, Tpe and Tpe/QTc ratio significantly correlated with disease duration. All HRV parameters (VLF, LF, HF, SDNN, SDANN, ASDNN, rMSSD, pNN50) were decreased in AS patients in comparison with those in control subjects (p < 0.05 for all parameters). Controls were significantly more likely to have normal TO and TS (82% vs 53%, p < 0.001). There was negative correlation between Holter parameters and disease duration, as well as Tpe and Tpe/QTc ratio (p < 0.05 for all parameters).

Conclusions

This study demonstrated that AS patients have disrupted ventricular repolarization (increased Tpe, Tpe/QTc ratio). Results suggest a decreased cardiac impact of the parasympathetic system in AS patients.

Key Points

• This study demonstrated that AS patients have disrupted ventricular repolarization.

• The study also finds that heart rate turbulence and heart rate variability are impaired in AS patients.

• Impaired Holter and ECG parameters may be one of the high cardiovascular risk factors in AS patients.

van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368CrossRef

Bergfeldt L, Edhag O, Vallin H (1982) Cardiac conduction disturbances, an underestimated manifestation in ankylosing spondylitis. A 25-year follow-up study of 68 patients. Acta Med Scand 212(4):217–223CrossRef

Bergfeldt L, Edhag O, Vedin L, Vallin H (1982) Ankylosing spondylitis: an important cause of severe disturbances of the cardiac conduction system. Prevalence among 223 pacemaker-treated men. Am J Med 73(2):187–191. https://doi.org/10.1016/0002-9343(82)90177-2CrossRefPubMed

Bulkley BH, Roberts WC (1973) Ankylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation 48(5):1014–1027. https://doi.org/10.1161/01.cir.48.5.1014CrossRefPubMed

Heslinga SC, Van Dongen CJ, Konings TC, Peters MJ, Van der Horst-Bruinsma IE, Smulders YM, Nurmohamed MT (2014) Diastolic left ventricular dysfunction in ankylosing spondylitis--a systematic review and meta-analysis. Semin Arthritis Rheum 44(1):14–19. https://doi.org/10.1016/j.semarthrit.2014.02.004CrossRefPubMed

Julkunen H (1966) Atrioventricular conduction defect in ankylosing spondylitis. Geriatrics 21(10):129–131PubMed

O’Neill TW, Bresnihan B (1992) The heart in ankylosing spondylitis. Ann Rheum Dis 51(6):705–706. https://doi.org/10.1136/ard.51.6.705CrossRefPubMedPubMedCentral

Kazmierczak J, Peregud-Pogorzelska M, Biernawska J, Przepiera-Bedzak H, Goracy J, Brzosko I, Plonska E, Brzosko M (2007) Cardiac arrhythmias and conduction disturbances in patients with ankylosing spondylitis. Angiology 58(6):751–756. https://doi.org/10.1177/0003319707299208CrossRefPubMed

Forsblad-d’Elia H, Wallberg H, Klingberg E, Carlsten H, Bergfeldt L (2013) Cardiac conduction system abnormalities in ankylosing spondylitis: a cross-sectional study. BMC Musculoskelet Disord 14:237. https://doi.org/10.1186/1471-2474-14-237CrossRefPubMedPubMedCentral

10.

Radford EP, Doll R, Smith PG (1977) Mortality among patients with ankylosing spondylitis not given X-ray therapy. N Engl J Med 297(11):572–576. https://doi.org/10.1056/nejm197709152971103CrossRefPubMed

11.

Umetani K, Singer DH, McCraty R, Atkinson M (1998) Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades. J Am Coll Cardiol 31(3):593–601CrossRef

12.

Otzenberger H, Gronfier C, Simon C, Charloux A, Ehrhart J, Piquard F, Brandenberger G (1998) Dynamic heart rate variability: a tool for exploring sympathovagal balance continuously during sleep in men. Am J Phys 275(3):H946–H950. https://doi.org/10.1152/ajpheart.1998.275.3.H946CrossRef

13.

DeGiorgio CM, Miller P, Meymandi S, Chin A, Epps J, Gordon S, Gornbein J, Harper RM (2010) RMSSD, a measure of vagus-mediated heart rate variability, is associated with risk factors for SUDEP: the SUDEP-7 inventory. Epilepsy Behav 19(1):78–81. https://doi.org/10.1016/j.yebeh.2010.06.011

14.

Taylor JA, Carr DL, Myers CW, Eckberg DL (1998) Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation 98(6):547–555. https://doi.org/10.1161/01.cir.98.6.547CrossRefPubMed

15.

Reyes del Paso GA, Langewitz W, Mulder LJ, van Roon A, Duschek S (2013) The utility of low frequency heart rate variability as an index of sympathetic cardiac tone: a review with emphasis on a reanalysis of previous studies. Psychophysiology 50(5):477–487. https://doi.org/10.1111/psyp.12027CrossRefPubMed

16.

Grossman P, Taylor EW (2007) Toward understanding respiratory sinus arrhythmia: relations to cardiac vagal tone, evolution and biobehavioral functions. Biol Psychol 74(2):263–285. https://doi.org/10.1016/j.biopsycho.2005.11.014CrossRefPubMed

17.

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996). Circulation 93 (5):1043–1065

18.

Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN (1992) Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 85(1):164–171. https://doi.org/10.1161/01.cir.85.1.164CrossRefPubMed

19.

Tsuji H, Venditti FJ Jr, Manders ES, Evans JC, Larson MG, Feldman CL, Levy D (1994) Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 90(2):878–883. https://doi.org/10.1161/01.cir.90.2.878CrossRefPubMed

20.

Lin LY, Lai LP, Lin JL, Du CC, Shau WY, Chan HL, Tseng YZ, Huang SK (2002) Tight mechanism correlation between heart rate turbulence and baroreflex sensitivity: sequential autonomic blockade analysis. J Cardiovasc Electrophysiol 13(5):427–431CrossRef

21.

Castro Hevia J, Antzelevitch C, Tornes Barzaga F, Dorantes Sanchez M, Dorticos Balea F, Zayas Molina R, Quinones Perez MA, Fayad Rodriguez Y (2006) Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol 47(9):1828–1834. https://doi.org/10.1016/j.jacc.2005.12.049CrossRefPubMed

22.

Erikssen G, Liestol K, Gullestad L, Haugaa KH, Bendz B, Amlie JP (2012) The terminal part of the QT interval (T peak to T end): a predictor of mortality after acute myocardial infarction. Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 17(2):85–94. https://doi.org/10.1111/j.1542-474X.2012.00493.xCrossRef

23.

Tsuji H, Larson MG, Venditti FJ Jr, Manders ES, Evans JC, Feldman CL, Levy D (1996) Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 94(11):2850–2855. https://doi.org/10.1161/01.cir.94.11.2850CrossRefPubMed

24.

Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, Camm AJ, Bigger JT Jr, Schomig A (1999) Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet (London, England) 353(9162):1390–1396. https://doi.org/10.1016/s0140-6736(98)08428-1CrossRef

25.

Martins NA, Furtado GE, Campos MJ, Leitao JC, Filaire E, Ferreira JP (2014) Exercise and ankylosing spondylitis with New York modified criteria: a systematic review of controlled trials with meta-analysis. Acta Reumatol Port 39(4):298–308PubMed

26.

Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing spondylitis disease activity index. J Rheumatol 21(12):2286–2291PubMed

27.

Gunes Y, Tuncer M, Guntekin U, Sahin M, Yazmalar L (2009) Effects of ankylosing spondylitis on the heart. Acta Cardiol 64(3):385–392. https://doi.org/10.2143/ac.64.3.2038026CrossRefPubMed

28.

Kaya EB, Okutucu S, Aksoy H, Karakulak UN, Tulumen E, Ozdemir O, Inanici F, Aytemir K, Kabakci G, Tokgozoglu L, Ozkutlu H, Oto A (2010) Evaluation of cardiac autonomic functions in patients with ankylosing spondylitis via heart rate recovery and heart rate variability. Clinical Research in Cardiology : Official Journal of the German Cardiac Society 99(12):803–808. https://doi.org/10.1007/s00392-010-0187-xCrossRef

29.

Yildirir A, Aksoyek S, Calguneri M, Aytemir K, Kabakci G, Ovunc K, Nazli N, Ozmen F, Oto A, Kes S (2000) QT dispersion as a predictor of arrhythmic events in patients with ankylosing spondylitis. Rheumatology (Oxford, England) 39(8):875–879. https://doi.org/10.1093/rheumatology/39.8.875CrossRef

30.

Borman P, Gokoglu F, Kocaoglu S, Yorgancioglu ZR (2008) The autonomic dysfunction in patients with ankylosing spondylitis: a clinical and electrophysiological study. Clin Rheumatol 27(10):1267–1273. https://doi.org/10.1007/s10067-008-0906-0CrossRefPubMed

31.

Thayer JF, Yamamoto SS, Brosschot JF (2010) The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol 141(2):122–131. https://doi.org/10.1016/j.ijcard.2009.09.543CrossRefPubMed

32.

Thomsen NH, Horslev-Petersen K, Beyer JM (1986) Ambulatory 24-hour continuous electrocardiographic monitoring in 54 patients with ankylosing spondylitis. Eur Heart J 7(3):240–246. https://doi.org/10.1093/oxfordjournals.eurheartj.a062058CrossRefPubMed

33.

Lehtinen K (1993) Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 52(3):174–176. https://doi.org/10.1136/ard.52.3.174CrossRefPubMedPubMedCentral

34.

Shaffer F, Ginsberg JP (2017) An overview of heart rate variability metrics and norms. Front Public Health 5:258. https://doi.org/10.3389/fpubh.2017.00258CrossRefPubMedPubMedCentral

35.

Ponikowski P, Anker SD, Chua TP, Szelemej R, Piepoli M, Adamopoulos S, Webb-Peploe K, Harrington D, Banasiak W, Wrabec K, Coats AJ (1997) Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 79(12):1645–1650. https://doi.org/10.1016/s0002-9149(97)00215-4CrossRefPubMed

36.

La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ (1998) Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes after Myocardial Infarction) Investigators. Lancet (London, England) 351(9101):478–484. https://doi.org/10.1016/s0140-6736(97)11144-8CrossRef

37.

Toussirot E, Bahjaoui-Bouhaddi M, Poncet JC, Cappelle S, Henriet MT, Wendling D, Regnard J (1999) Abnormal autonomic cardiovascular control in ankylosing spondylitis. Ann Rheum Dis 58(8):481–487. https://doi.org/10.1136/ard.58.8.481CrossRefPubMedPubMedCentral

38.

Poddubnyi DA, Gaidukova IZ, Rebrov AP (2009) Heart rate variability in patients with ankylosing spondylitis (Bekhterev’s disease). Terapevticheskii arkhiv 81(6):56–62PubMed

39.

Wei CY, Kung WM, Chou YS, Wang YC, Tai HC, Wei JC (2016) Cardiac autonomic function in patients with ankylosing spondylitis: a case-control study. Medicine 95(21):e3749. https://doi.org/10.1097/md.0000000000003749CrossRefPubMedPubMedCentral

40.

Yildirir A, Aksoyek S, Calguneri M, Aytemir K, Apras S, Kiraz S, Kabakci G, Ovunc K, Oto A, Kes S (2001) No evidence of cardiac autonomic involvement in ankylosing spondylitis, as assessed by heart rate variability. Clin Rheumatol 20(3):185–188CrossRef

41.

Pagani M, Lombardi F, Guzzetti S, Sandrone G, Rimoldi O, Malfatto G, Cerutti S, Malliani A (1984) Power spectral density of heart rate variability as an index of sympatho-vagal interaction in normal and hypertensive subjects. Journal of Hypertension Supplement : Official Journal of the International Society of Hypertension 2(3):S383–S385

42.

Lin K, Wei L, Huang Z, Zeng Q (2017) Combination of Ewing test, heart rate variability, and heart rate turbulence analysis for early diagnosis of diabetic cardiac autonomic neuropathy. Medicine 96(45):e8296. https://doi.org/10.1097/md.0000000000008296CrossRefPubMedPubMedCentral

43.

Cygankiewicz I (2013) Heart rate turbulence. Prog Cardiovasc Dis 56(2):160–171. https://doi.org/10.1016/j.pcad.2013.08.002CrossRefPubMed

44.

Ghuran A, Reid F, La Rovere MT, Schmidt G, Bigger JT Jr, Camm AJ, Schwartz PJ, Malik M (2002) Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (the autonomic tone and reflexes after myocardial infarction substudy). Am J Cardiol 89(2):184–190. https://doi.org/10.1016/s0002-9149(01)02198-1CrossRefPubMed

45.

Peeters AJ, ten Wolde S, Sedney MI, de Vries RR, Dijkmans BA (1991) Heart conduction disturbance: an HLA-B27 associated disease. Ann Rheum Dis 50(6):348–350. https://doi.org/10.1136/ard.50.6.348CrossRefPubMedPubMedCentral

46.

Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT, Yan GX (2008) T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol 41(6):567–574. https://doi.org/10.1016/j.jelectrocard.2008.07.016CrossRefPubMed

47.

Zhao X, Xie Z, Chu Y, Yang L, Xu W, Yang X, Liu X, Tian L (2012) Association between Tp-e/QT ratio and prognosis in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Clin Cardiol 35(9):559–564. https://doi.org/10.1002/clc.22022CrossRefPubMedPubMedCentral

48.

Acar G, Yorgun H, Inci MF, Akkoyun M, Bakan B, Nacar AB, Dirnak I, Cetin GY, Bozoglan O (2014) Evaluation of Tp-e interval and Tp-e/QT ratio in patients with ankylosing spondylitis. Mod Rheumatol 24(2):327–330. https://doi.org/10.3109/14397595.2013.854072CrossRefPubMed

Title: Evaluation of cardiac autonomic nervous system in patients with ankylosing spondylitis using 12-lead electrocardiography and Holter monitoring
Authors: Mustafa Candemir
Burcu Candemir
Adem Ertürk
Publication date: 01-09-2020
Publisher: Springer International Publishing
Keywords: Electrocardiography
Ankylosing Spondylitis
Electrocardiography
Published in: Clinical Rheumatology / Issue 9/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-020-05046-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Evaluation of cardiac autonomic nervous system in patients with ankylosing spondylitis using 12-lead electrocardiography and Holter monitoring

Abstract

Objectives

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2020

Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus

Dynamic changes in gut microbiota under the influence of smoking and TNF-α-blocker in patients with ankylosing spondylitis

Determinants of COVID-19 disease severity in patients with underlying rheumatic disease

A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab

Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review

Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page